GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sailong Pharmaceutical Group Co Ltd (SZSE:002898) » Definitions » 3-Year Book Growth Rate

Sailong Pharmaceutical Group Co (SZSE:002898) 3-Year Book Growth Rate : -3.00% (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Sailong Pharmaceutical Group Co 3-Year Book Growth Rate?

Sailong Pharmaceutical Group Co's Book Value per Share for the quarter that ended in Mar. 2024 was ¥3.05.

During the past 12 months, Sailong Pharmaceutical Group Co's average Book Value per Share Growth Rate was 1.50% per year. During the past 3 years, the average Book Value per Share Growth Rate was -3.00% per year. During the past 5 years, the average Book Value per Share Growth Rate was -5.00% per year. During the past 10 years, the average Book Value per Share Growth Rate was 0.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 11 years, the highest 3-Year average Book Value per Share Growth Rate of Sailong Pharmaceutical Group Co was 32.70% per year. The lowest was -47.30% per year. And the median was -2.35% per year.


Competitive Comparison of Sailong Pharmaceutical Group Co's 3-Year Book Growth Rate

For the Biotechnology subindustry, Sailong Pharmaceutical Group Co's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sailong Pharmaceutical Group Co's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sailong Pharmaceutical Group Co's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Sailong Pharmaceutical Group Co's 3-Year Book Growth Rate falls into.



Sailong Pharmaceutical Group Co 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.


Sailong Pharmaceutical Group Co  (SZSE:002898) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.


Sailong Pharmaceutical Group Co 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Sailong Pharmaceutical Group Co's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Sailong Pharmaceutical Group Co (SZSE:002898) Business Description

Traded in Other Exchanges
N/A
Address
No. 47, Haibin South Road, 2nd Floor, Everbright International Trade Center, Guangdong Province, Zhuhai, CHN, 519015
Zhuhai Sailong Pharmaceutical Co Ltd is the pharmaceutical company. It is mainly engaged in the development, production, marketing and technical services of pharmaceuticals. The company's products are mainly concentrated in the fields of the nervous system, cardiovascular and digestive system. The product range includes monosialin tetrahexose ganglioside sodium injections, brain protein hydrolyzate for injections, clindamycin phosphate for injections, pantoprazole sodium for injections and milrinon injections, among others.

Sailong Pharmaceutical Group Co (SZSE:002898) Headlines

No Headlines